🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

UPDATE 2-New Zealand's A2 Milk says half-year profits jump on China sales

Published 15/02/2017, 12:30 pm
© Reuters.  UPDATE 2-New Zealand's A2 Milk says half-year profits jump on China sales

* A2 says baby formula demand in China stoked profits

* Says broad distribution system helped China sales

* Shares hit record high after profit announcement (Adds comment, detail)

WELLINGTON, Feb 15 (Reuters) - New Zealand dairy firm A2 Milk Company Ltd ATM.NZ on Wednesday said its half-year profits jumped nearly 300 percent, boosted by sales of baby formula in the hotly-contested China market.

A2 shares rose more than 5 percent to a record high of NZ$2.68 after it posted a net profit after tax for the six months to Dec. 31 of NZ$39.4 million ($28.2 million). That compared to about NZ$10 million in the same period last year.

"The outstanding aspect of our half-year performance was the continuing growth in a2 Platinum infant formula through a multi-channel strategy involving a combination of local distribution, e-commerce, and overseas shopping traders," Managing Director Geoffrey Babidge said in a statement.

The company said the use of so-called 'daigou' was a growing sales channel to China. Meaning 'buy on behalf of' in Chinese, daigou buyers are individuals based abroad who ship sought-after products to buyers back home.

A2's results contrast with rival Australian baby formula company Bellamy's, which cut its revenue forecast in January, sending shares plummeting 40 percent. survey published last week by brokerage firm UBS showed A2's online brand recognition among Chinese parents and expectant mothers was just over 40 percent, double that of Bellamy's.

"You've got to keep all the channels open where China is concerned ... the daigou is the best at one stage, the direct sales, the internet sales at another," said Bryan Gaynor director of investment firm Milford Asset Management, which owns A2 shares.

A2, which produces milk free from a protein that it says causes gut problems in some milk drinkers, has recently expanded in major U.S. supermarkets and has focused heavily on the Chinese market, where revenues increased by 348 percent to NZ$37.7 million.

The company expects infant formula profits in the next six-month period to drop from the previous half, partly because there are less major Chinese sales events scheduled.

A2 said its board planned to adopt a dividend policy at the end of full-year 2017.

($1 = 1.3965 New Zealand dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.